Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MTNR1A | P48039 | 9/20 | 0.55 |
| ▸ | MTNR1B | P49286 | 9/20 | 0.53 |
| ▸ | NQO2 | P16083 | 8/20 | 0.53 |
| ▸ | ACHE | P22303 | 4/20 | 0.51 |
| ▸ | CA1 | P00915 | 2/20 | 0.51 |
| ▸ | CA2 | P00918 | 2/20 | 0.51 |
| ▸ | C5AR1 | P21730 | 1/20 | 0.49 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL19839761 | 0.89 | MTNR1A (0.50) | MTNR1AMTNR1BNQO2ACHECA1 | |
| SCHEMBL10469093 | 0.84 | C5AR1 (0.49) | MTNR1AMTNR1BNQO2ACHEC5AR1 | |
| SCHEMBL30746730 | 0.84 | MTNR1A (0.56) | MTNR1AMTNR1BNQO2 | |
| SCHEMBL19838588 | 0.84 | MTNR1A (0.59) | MTNR1AMTNR1BNQO2 | |
| SCHEMBL1842495 | 0.84 | MTNR1A (0.56) | MTNR1AMTNR1BNQO2 | |
| SCHEMBL10467839 | 0.82 | C5AR1 (0.48) | MTNR1AMTNR1BNQO2C5AR1 | |
| SCHEMBL2842735 | 0.82 | MTNR1A (0.58) | MTNR1AMTNR1BNQO2 | |
| Hydrochloric Acid SCHEMBL9628615 | 0.82 | MTNR1A (0.54) | MTNR1AMTNR1BNQO2 | |
| SCHEMBL2825083 | 0.82 | MTNR1A (0.54) | MTNR1AMTNR1BNQO2 | |
| SCHEMBL9628604 | 0.82 | MTNR1A (0.54) | MTNR1AMTNR1BNQO2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2018026371-A1 | DUAL NAV1.2/5HT2A INHIBITORS FOR TREATING CNS DISORDERS | SUNOVION PHARMACEUTICALS INC. (US) | 2018-02-08 | — | — | WO | disclosed |